Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Neurocrine Biosciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 06:20PM GMT
Release Date Price: $112.48 (-0.96%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Good afternoon, everybody. Welcome to the Bank of America Health Care Conference. My name is Tazeen Ahmad. I am one of the Senior Biotech Analysts at the firm.

It is my pleasure to have our next presenting company, Neurocrine. For the next 30 minutes, I'll be spending time with CEO, Kevin Gorman. Talking about the company and some upcoming catalysts. Kevin, good afternoon, thanks for joining us.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Good afternoon, Tazeen, and thank you very much for having us here today.

Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP

Our pleasure. So I like to open up every conversation with a 2-minute summary of the company and some of your key accomplishments. And if you don't mind giving us a 2-minute pitch, we can go straight into questions from there.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Certainly, Tazeen. I will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot